ACR/ARHP 2014: HM-0523 (HMPL-523), a novel Syk inhibitor, blocks glomerulonephritis and extends life spans in lupus prone MRL/lpr mice // Chi-Med
AIM: £38.00 (+0.5) | Nasdaq: $24.98 (-0.06)
News Archive
Previous Article   |   Next Article
Presentations | 14 Oct 2014

ACR/ARHP 2014: HM-0523 (HMPL-523), a novel Syk inhibitor, blocks glomerulonephritis and extends life spans in lupus prone MRL/lpr mice

View Presentation (PDF)View Presentation (PDF)

1 Item
View Poster (JPG)